Tepezza®

Tepezza® (teprotumumab-trbw) is an insulin-like growth factor-1 receptor inhibitor used to treat Thyroid Eye Disease, an autoimmune disease characterized by proptosis (a condition where the eyes are pushed forward and bulge outward) leading to eye pain double vision and difficulty closing the eyelid.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

Tepezza® Referral Form